M&A Corner
Amino Health Receives $42M Credit Facility.25 Jul 2023
California-based healthcare-navigation platform Amino Health has secured $42 million in credit financing from Oxford Finance, as part of its $80... Continue Reading
|
SiPhox Health Secures $27M for Lab-Grade Home Health Testing with Silicon Photonics25 Jul 2023
SiPhox Health, a Massachusetts-based company, has raised $27 million in funding to develop lab-grade home health testing using silicon photonics.... Continue Reading
|
Herself Health Raises $26M To Power Primary Care for Women 65+25 Jul 2023
New York City-based healthcare company Herself Health has raised $26 million in a Series A funding round led by Michael... Continue Reading
|
BioCryst Selects Er-Kim Pharmaceuticals as Commercial Partner for ORLADEYO® (berotralstat) in Turkey.25 Jul 2023
BioCryst Pharmaceuticals has partnered with Er-Kim Pharmaceuticals to commercialize ORLADEYO (berotralstat) in Turkey. This collaboration aims to make the oral,... Continue Reading
|
Lifebit Partners with Latin American Innovators to Assist Genomic Diversity25 Jul 2023
Lifebit, a precision medicine software provider in London, has partnered with two population genomic initiatives in Mexico and Brazil to... Continue Reading
|
Reimagine Care, DispatchHealth Partner for Home Oncology Care.25 Jul 2023
Reimagine Care, a home-based cancer care platform, has partnered with DispatchHealth, an in-home care provider, to offer virtual-to-home care for... Continue Reading
|
FTC Digs Deeper into Pfizer’s $43B Buyout of Seagen25 Jul 2023
The Federal Trade Commission (FTC) has requested additional information from Pfizer regarding its proposed acquisition of Seagen, a cancer-focused biotech.... Continue Reading
|
Unchained Labs Goes all in on Lipid Nanoparticles, Acquires Blacktrace Holdings!25 Jul 2023
Unchained Labs, a life sciences company, has acquired Blacktrace Holdings, known for its Dolomite microfluidics and Particle Works solutions. The... Continue Reading
|
Pardes Biosciences Enters into Agreement to be Acquired by MediPacific, Inc. for between $2.02 and $2.19 in Cash per Share Plus Contingent Value Rights25 Jul 2023
Pardes Biosciences, Inc. will be acquired by MediPacific, Inc. for a cash price per share between $2.02 and $2.19, depending... Continue Reading
|
Ligand Offers $15 Million to Acquire Assets of Novan, Inc.25 Jul 2023
Ligand Pharmaceuticals has offered to acquire the assets of Novan for $15 million in cash and provide up to $15... Continue Reading
|